Gohealth Inc expected to post a loss of 29 cents a share - Earnings Preview

GoHealth

05/05/2025 13:48

Gohealth Inc GOCO.OQ GOCO.O is expected to show a rise in quarterly revenue when it reports  results on May 7 (estimated) for the period ending March 31 2025

The Chicago Illinois-based  company is expected to report a 18.6% increase in revenue to $220.153 million from $185.6 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Gohealth Inc is for a loss of 29 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Gohealth Inc is $23.00​, above​ its last closing price of $8.81. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
1.30
1.16
2.19
Beat
88.3
Sep. 30 2024
-3.29
-3.19
0.46
Beat
114.4
Jun. 30 2024
-2.36
-2.47
-2.70
Missed
-9.2​
Mar. 31 2024
-0.96
-0.95
-1.04
Missed
-9.1
​​Dec. 31 2023
2.74
2.73
-0.22
Missed
-108.1
Sep. 30 2023
-2.90
-2.90
-2.61
Beat
10​
Jun. 30 2023
-2.33
-2.92
-3.27
Missed
-12.1
Mar. 31 2023
-1.93
-1.96
-1.12
Beat
42.8

This summary was machine generated May 5 at 12:48 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)